Exploring the TOP2-mediated DNA double-strand breaks at TFE3 translocation sites has important implications in understanding the pathogenesis of Xp11.2 tRCC. The gene discussed is TOP2A; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.